Compound Profile: Viprogra
Viprogra 100mg is a pharmaceutical-grade sildenafil citrate preparation manufactured by Vipro Life Science for comprehensive laboratory research applications. This compound belongs to the phosphodiesterase type 5 (PDE5) inhibitor class and serves as a valuable tool for investigating cyclic guanosine monophosphate (cGMP) signalling pathways in cellular and molecular biology studies. Researchers at Stroid UK Shop utilise this preparation to examine vascular smooth muscle relaxation mechanisms, nitric oxide pathway modulation, and endothelial function assessment protocols.
Laboratory Applications
Scientific investigations with Viprogra examine PDE5 enzyme inhibition kinetics, studying how this mechanism affects cellular cGMP concentrations and downstream signalling cascades. Research teams evaluate the compound’s interaction with nitric oxide synthase pathways and analyse its effects on vascular tissue specimens in controlled laboratory environments. The preparation enables detailed analysis of phosphodiesterase selectivity profiles and comparative studies alongside other erection drugs available for research purposes. Laboratories investigate dose-response relationships in tissue culture systems and examine the compound’s stability under various experimental conditions. Advanced research protocols utilise this preparation for molecular pharmacology studies, examining receptor binding affinities and evaluating therapeutic index calculations compared to compounds available in SARMs and peptides categories.
Analytical Specifications
| Active Compound | Sildenafil Citrate |
|---|---|
| Strength | 100mg per unit |
| Manufacturer | Vipro Life Science |
| Product Code | EU14909 |
| Chemical Formula | C₂₈H₃₈N₆O₁₁S |
| Molecular Weight | 666.7 g/mol |
| Storage Requirements | Room temperature, dry conditions |
| Research Classification | PDE5 Inhibitor |
Research Compliance Statement
Viprogra 100mg is manufactured exclusively for in-vitro research purposes and laboratory analytical studies. This preparation is not intended for human consumption, clinical application, or therapeutic use. Researchers must maintain appropriate laboratory protocols and safety measures when handling this compound. All studies should comply with institutional research guidelines and regulatory frameworks governing pharmaceutical research compounds.
